ONXEO
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Jun 2021)
What this means for you
Registered since 22 Sept 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86288671
- Registration number
- 4815827
- Mark type
- Design + words
- Filed
- 22 May 2014
- Published for opposition
- 10 Mar 2015
- Registered
- 22 Sept 2015
- Attorney of record
- Ben Natter
Goods and services
- Class 042 — Scientific and technological services: product research, namely, research services for conceiving and developing innovative products in the field of oncology
Owner
- VALERIO THERAPEUTICS S.A., PARIS, FR
- ONXEO, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
- BIOALLIANCE PHARMA, Paris, FR
Prosecution history
- 22 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 Jul 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jul 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 24 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Feb 2021 — TEAS SECTION 8 & 15 RECEIVED
- 22 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 22 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2015 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION